Innocan Pharma focuses on innovative non-opioid solutions for chronic pain management and wellness, with services including pharmaceuticals, human and animal health, and wellness products, self-described.

Innocan Pharma

InnoCan Pharma | 2,261 followers on LinkedIn. (CSE:INNO) (FSE:IP4) (OTCQB:INNPF)
 | InnoCan Pharma is a pharmaceutical company specializing in developing novel therapeutics that harness the unique healing properties of Cannabinoids to improve quality of life. 

OUR ADVANTAGES 
Led by a highly-experienced team with a proven track record of success, InnoCan will leverage Israel’s worldleading medical cannabis research community to develop powerful, Cannabinoid-combined, patent-pending formulas. Our outstanding products will be clinically validated by undertaking Post Marketing Surveillance (PMS) studies and combine smart delivery systems to enhance the potency and efficacy of current products for better results.

Investor at RedC Biotech Ltd.

Smadar Shilo

DeepTech Investor ✮ Digital Transformation & Sustainable Manufacturing (i5.0) ✮ Business & Product Innovation

Zvika Weinshtock

CEO at InnoCan Pharma (CSE:INNO) (FSE:IP4) (OTCQB:INNPF)

Iris Bincovich

Analytical chemist with experience in energetic materials, fuels, oils, pharma and polymers

Nissim Vasilevski

InnoCan Pharma

A Novel Solution: LPT-CBD for Chronic Pain Relief

Innocan is proud to announce the relaunch of its newly updated website

These findings, highlights the long-lasting effects of repeated administration of LPT-CBD to treat chronic pain

We are incredibly proud of Dr. Pergolizzi's well-deserved recognition as one of the most-cited scientists worldwide

We are celebrating our 5th anniversary as a public company. In summary: We have demonstrated stability and achieving milestones in our research that has brought our flagship product "Liposomal CBD" (LPD) from the conceptual phase to the successful FDA Pre IND meeting .

May the New Year bring good news, hope, and peace to us all.

We are very excited about our next steps… https://lnkd.in/ddwAWVSv

Innocan reports: LTP injections https://lnkd.in/dZnEnTqW

I am excited to present Innocan Pharma Wellness next week, at White label expo in London…

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 11, 2024 9:10 AM	071c4b3d
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 11, 2024 9:10 AM	3b2cf2b7
crunchbase trigger	general	Nov 27, 2024 12:50 PM	bdd16cef
crunchbase profile	general
li profile	general	Nov 11, 2024 9:10 AM	98697b93
translate crunchbase fundingrounds	general
peers	general	Nov 11, 2024 9:10 AM	a626712e
news basic	general	Nov 11, 2024 9:10 AM	0a6ef550
bundesanzeiger	filings
financials download nd	financials
private financials	financials

INNO

COM:INNOCANPHARMA

Innocan Pharma